Nautilus Biotechnology, Inc. (NAUT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Nautilus Biotechnology, Inc. (NAUT)
Company Performance

Current Price

as of Oct 16, 2024

$2.96

P/E Ratio

N/A

Market Cap

$371.22M

Description

Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Metrics

Overview

  • HQSeattle, WA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerNAUT
  • Price$2.96+4.23%

Trading Information

  • Market Cap$371.22M
  • Float59.80%
  • Average Daily Volume (1m)75,637
  • Average Daily Volume (3m)69,396
  • EPS-$0.56

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$18.01M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$19.19M
  • EV$158.40M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B1.58
Documents